Company / Operating Cash Flow per Share
Bristol Myers Squibb Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$6.81
FY2025
5-year range
$4.80 / $7.22
FY2021-FY2025
Trend
-3.8%
vs FY2024
Sector context
#18 of 212
Health Care
What the data says
Among 212 Health Care companies, Bristol Myers Squibb is in the top 8% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $1.82 in FY2018 to $8.58 in FY2020.
Based on SEC 10-K filings.
6.81 in FY2025 with a 5-year CAGR of -4.5%. Top quartile in the Health Care sector.
Declined from $7.22 to $6.81 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- -4.5%
- 10-Year CAGR
- -
Sector benchmark
+146.3% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 3.8% year-over-year.
- Ranks #18 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.81 | -3.8% |
| FY2024 | $7.08 | -2.0% |
| FY2023 | $7.22 | +16.0% |
| FY2022 | $6.22 | +29.8% |
| FY2021 | $4.80 | -44.1% |
| FY2020 | $8.58 | +168.8% |
| FY2019 | $3.19 | +75.4% |
| FY2018 | $1.82 | -42.1% |
| FY2017 | $3.14 | +66.7% |
| FY2016 | $1.89 | -11.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026